A Look At Pulse Biosciences (PLSE) Valuation As Thyroid Cancer Feasibility Study Begins [Yahoo! Finance]
Pulse Biosciences, Inc (PLSE)
Last pulse biosciences, inc earnings: 11/7 03:42 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.pulsebiosciences.com
Company Research
Source: Yahoo! Finance
Pulse Biosciences (PLSE) shares are in focus after the company reported first patient enrollments and initial treatments in a multicenter feasibility study of its nsPFA based Vybrance system for early stage papillary thyroid cancer. See our latest analysis for Pulse Biosciences. The Vybrance thyroid cancer study comes after a series of recent thyroid focused updates and conference presentations, with the 7 day share price return of 18.16% and 90 day share price return of 51.58% suggesting building momentum despite a 6.26% 30 day share price pullback and mixed long term total shareholder returns. If this kind of clinical progress has your attention, it could be worth widening your search with a screener of other healthcare focused AI names such as 34 healthcare AI stocks With shares up 61.09% year to date and trading at US$21.57 versus an analyst price target of US$30.00, you have to ask: is Pulse Biosciences still misunderstood, or is the market already pricing in future grow
Show less
Read more
Impact Snapshot
Event Time:
PLSE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PLSE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PLSE alerts
High impacting Pulse Biosciences, Inc news events
Weekly update
A roundup of the hottest topics
PLSE
News
- Truffle Capital Unveils the First Edition of the Truffle MedTech 10 [Yahoo! Finance]Yahoo! Finance
- Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data [Yahoo! Finance]Yahoo! Finance
- Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical DataBusiness Wire
- Is Pulse Biosciences' (PLSE) Thyroid Cancer Feasibility Study a Prelude to a Broader Platform Strategy? [Yahoo! Finance]Yahoo! Finance
- Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology [Yahoo! Finance]Yahoo! Finance
PLSE
Earnings
- 2/19/26 - Beat
PLSE
Sec Filings
- 3/17/26 - Form 8-K
- 3/12/26 - Form 8-K
- 3/9/26 - Form 8-K
- PLSE's page on the SEC website